Here, we assessed if targeting GLS in vascular ECs affects pathologic angiogenesis, tumor blood vessel structure and function, and tumorigenesis and metastasis, as GLS2 is expressed at low level in ECs (16). The gene discussed is GLS; the disease is neoplasm.